Medical and Health Informatics Laboratories, NTT Research, Inc., Sunnyvale, California, United States.
Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center, Osaka, Japan.
Am J Physiol Regul Integr Comp Physiol. 2024 Sep 1;327(3):R349-R361. doi: 10.1152/ajpregu.00009.2024. Epub 2024 Jul 15.
Angiotensin II (ANG II) is known to play an important role in regulating renal hemodynamics. We sought to quantify this effect in an in vivo rat model with high-resolution renal arterial (RA) impedance. This study examines the effects of ANG II and its type 1 receptor blocker telmisartan (TELM) on RA impedance. In baroreflex-deactivated rats, we measured RA pressure () and blood flow () during random ventricular pacing to induce pressure fluctuation at three different mean (60, 80, and 100 mmHg). We then estimated RA impedance as the transfer function from to . The RA impedance was found to align with a three-element Windkessel model consisting of proximal () and distal () resistance and compliance (). Our study showed reflected the composite characteristics of afferent and efferent arterioles. increased with increasing under the baseline condition with a slope of 1.03 ± 0.21 (× 10) min·mL. ANG II significantly increased the slope by 0.72 ± 0.29 (× 10) min·mL ( < 0.05) without affecting the intercept. TELM significantly reduced the intercept by 34.49 ± 4.86 (× 10) mmHg·min·mL ( < 0.001) from the baseline value of 37.93 ± 13.36 (× 10) mmHg·min·mL, whereas it did not affect the slope. In contrast, was less sensitive than to ANG II or TELM, suggesting may represent the characteristics of elastic large arteries. Our findings provide valuable insights into the influence of ANG II on the dynamics of the renal vasculature. This present method of quantifying high-resolution renal arterial impedance could contribute to elucidating the characteristics of renal vasculature influenced by physiological mechanisms, renal diseases, or pharmacological effects. The present findings help construct a lumped-parameter renal hemodynamic model that reflects the influence of angiotensin II.
血管紧张素 II(ANG II)在调节肾脏血液动力学方面起着重要作用。我们试图在具有高分辨率肾动脉(RA)阻抗的体内大鼠模型中量化这种作用。本研究探讨了 ANG II及其 1 型受体阻滞剂替米沙坦(TELM)对 RA 阻抗的影响。在降压反射失活的大鼠中,我们在随机心室起搏期间测量 RA 压力()和血流(),以在三个不同的平均(60、80 和 100mmHg)下诱导压力波动。然后,我们将 RA 阻抗估计为从到的传递函数。RA 阻抗与由近端()和远端()阻力和顺应性()组成的三元件风箱模型一致。我们的研究表明,反映了输入和输出小动脉的综合特征。在基线条件下,随着的增加,呈 1.03±0.21(×10)min·mL的斜率增加。ANG II 使斜率显著增加了 0.72±0.29(×10)min·mL(<0.05),而不影响截距。TELM 使截距从基线值 37.93±13.36(×10)mmHg·min·mL 降低了 34.49±4.86(×10)mmHg·min·mL(<0.001),而不影响斜率。相比之下,对 ANG II 或 TELM 的敏感性低于,这表明可能代表弹性大动脉的特征。我们的研究结果提供了关于 ANG II 对肾脏血管动力学影响的有价值的见解。这种量化高分辨率肾动脉阻抗的方法可以帮助阐明受生理机制、肾脏疾病或药物作用影响的肾血管特征。本研究结果有助于构建反映血管紧张素 II 影响的集中参数肾血液动力学模型。